MeiraGTx Holdings (MGTX) Income towards Parent Company (2017 - 2025)

MeiraGTx Holdings (MGTX) reported Income towards Parent Company of $23.7 million for Q4 2025, up 169.96% on a YoY basis from $8.8 million in Q4 2024, and up 148.4% quarter-over-quarter from -$49.0 million in Q3 2025.

MeiraGTx Holdings (MGTX) Income towards Parent Company (2017 - 2025) Analysis & Trends

MeiraGTx Holdings has reported Income towards Parent Company for 9 years, with the latest figure at $23.7 million in Q4 2025.

  • For the quarter ending Q4 2025, Income towards Parent Company rose 169.96% year-over-year to $23.7 million; the trailing twelve-month figure through Dec 2025 stood at -$116.3 million (up 32.88% YoY), and the FY2025 full-year result was -$116.3 million, up 32.88% from the prior year.
  • Income towards Parent Company for Q4 2025 stood at $23.7 million, up from -$49.0 million in the prior quarter.
  • The five-year high for Income towards Parent Company was $23.7 million in Q4 2025, with the low at -$49.0 million in Q3 2025.
  • Historically, Income towards Parent Company has averaged -$31.6 million across 5 years, with a median of -$34.1 million in 2023.
  • Annual changes were most pronounced in 2022 — Income towards Parent Company tumbled 459.0% — and 2025, when it surged 169.96%.
  • MeiraGTx Holdings' Income towards Parent Company stood at -$7.8 million in 2021, then plunged by 459.0% to -$43.5 million in 2022, then slipped by 7.21% to -$46.7 million in 2023, then rose by 27.4% to -$33.9 million in 2024, then soared by 169.96% to $23.7 million in 2025.
  • The last three Income towards Parent Company figures came in at $23.7 million (Q4 2025), -$49.0 million (Q3 2025), and -$47.4 million (Q2 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Alterity Therapeutics 925,601.88 Bn 925,601.85 Bn -
2 Belite Bio 58,560.00 Bn 58,560.00 Bn -
3 Quantum Biopharma 17,284.41 Bn 17,284.40 Bn -
4 Legend Biotech 2,809.00 Bn 2,808.71 Bn 242.10 Mn
5 Evaxion A 1,334.43 Bn 1,334.42 Bn -
6 Akari Therapeutics 1,312.27 Bn 1,312.26 Bn -
7 Psyence Biomedical 212.16 Bn 212.16 Bn -
8 Vertex Pharmaceuticals 114.83 Bn 107.58 Bn 2.59 Bn
9 Abivax 91.96 Bn 91.96 Bn -
10 MeiraGTx Holdings 910.47 Mn 844.54 Mn 74.89 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 23.70 Mn
Sep 30, 2025 -48.96 Mn
Jun 30, 2025 -47.42 Mn
Mar 31, 2025 -43.67 Mn
Dec 31, 2024 -33.87 Mn
Sep 30, 2024 -42.21 Mn
Jun 30, 2024 -48.34 Mn
Mar 31, 2024 -48.93 Mn
Dec 31, 2023 -46.65 Mn
Sep 30, 2023 -35.62 Mn
Jun 30, 2023 -31.49 Mn
Mar 31, 2023 -34.28 Mn
Dec 31, 2022 -43.52 Mn
Sep 30, 2022 -24.41 Mn
Jun 30, 2022 -23.80 Mn
Mar 31, 2022 -28.80 Mn
Dec 31, 2021 -7.79 Mn
Sep 30, 2021 -22.58 Mn
Jun 30, 2021 -20.47 Mn
Mar 31, 2021 -22.00 Mn